MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer
Yahoo Financearrow_outwardINKT's Investigational Cell Therapy Renders Testicular Cancer Patient Disease-free, Stock Soars
Nasdaqarrow_outwardSalvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor
Naturearrow_outwardMink Therapeutics announces publication of complete remission - MarketScreener
MarketScreenerarrow_outwardWhy Is MiNK Therapeutics Stock (INKT) Up 190% Today? - TipRanks
TipRanksarrow_outwardWhy Did INKT Stock Skyrocket in Todayโs Premarket Trading? - Tokenist
Tokenistarrow_outwardMiNK Therapeutics stock soars after cancer remission breakthrough - Investing.com
Investing.comarrow_outwardMiNK reports complete remission in refractory testicular cancer case By Investing.com - Investing.com South Africa
Investing.com South Africaarrow_outwardComplete Remission Achieved in Treatment-Resistant Testicular Cancer with iNKT Cell Therapy | INKT Stock News - Stock Titan
Stock Titanarrow_outwardMiNK Therapeutics (NASDAQ:INKT) Trading 0.6% Higher โ Should You Buy? - Defense World
Defense Worldarrow_outward(INKT) On The My Stocks Page - news.stocktradersdaily.com
News.stocktradersdaily.comarrow_outwardWTF with ALA: What are iNKT cell therapies? - Stockhead
Stockheadarrow_outwardMiNK Therapeutics, Inc. SEC 10-K Report - TradingView
TradingViewarrow_outwardBrightPath Bio and Cellistic Announce Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell - BioInformant
BioInformantarrow_outwardฮฑ-Lactosylceramide Protects Against iNKT-Mediated Murine Airway Hyperreactivity and Liver Injury Through Competitive Inhibition of Cd1d Binding - Frontiers
Frontiersarrow_outwardThe Best ASX Biotechnology Stocks - thebull.com.au
Thebull.com.auarrow_outwardMiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer - GlobeNewswire
GlobeNewswirearrow_outwardsymbol__ Stock Quote Price and Forecast - CNN
CNNarrow_outwardAgenus: 2024 May Finally Be The Year For A Major Turnaround - Seeking Alpha
Seeking Alphaarrow_outwardALA is our best performing stock in 2023 - hereโs why, and what to expect in 2024 - Next Investors
Next Investorsarrow_outwardTissue-specific metabolic profile drives iNKT cell function during obesity and liver injury - ScienceDirect.com
ScienceDirect.comarrow_outwardParallels and distinctions between ILC1s, iNKT and TRM. ILC1s, iNKT... - researchgate.net
Researchgate.netarrow_outwardInkt a haven for lovers of writing - NZ Herald
NZ Heraldarrow_outward
Inkt Stock close
- 2025-07-11 22:00 event
- 23 sourceslanguage
- 200+ ads_click
- 1 day ago schedule